As many as 14% of patch-tested patients show a positive reaction to gold, yet the result proves clinically meaningful in less than a third of those cases — one of several data points Brandon Adler, MD, used to argue that a positive patch test alone does not close the diagnostic loop in allergic contact dermatitis.

Adler, clinical associate professor and director of the Contact Dermatitis Clinic at the University of Southern California, Los Angeles, laid out common allergy misconceptions among physicians and patients at the fall symposium of the California Society of Dermatology and Dermatologic Surgery, held in Carlsbad, Calif.

His core message: handing a patient a list of positive allergens and telling them to stay away is not enough. "We need to give the patient a reference that will do the hard lifting for them when it comes to allergen avoidance," Adler said.

Why do patients blame the wrong exposures?

Patients with allergic reactions often arrive with "a lot of fear and misconceptions," Adler said. A patient with eyelid dermatitis, for example, might be "worried about something they're eating, worried about their laundry detergent."

Both suspicions are usually off target. Food and laundry detergents rarely cause allergic skin reactions, although it is possible, he noted. "It's been shown that modern washing machines reduce the concentrations of fragrances and allergenic preservatives to concentrations that are so low they shouldn't be able to cause allergic contact dermatitis."

How does allergy timing mislead patients?

Patients frequently assume new-onset contact dermatitis stems from something new in their lives. In reality, "there are usually multiple asymptomatic exposures that precede the development of allergy, with the exception of certain stronger allergens that we're not typically encountering in daily practice," Adler said.

Sensitization can emerge at any point — even months to years into a product's use. Once allergy is established, delayed hypersensitivity adds another confounder: "We're going to have hours, even as long as days, between exposure and rash."

His counseling strategy is direct: "We can explain to the patient that the more times you're exposed to something, the more opportunities your immune system has to decide that it doesn't like it."

When does a positive patch test fall short?

Physicians cannot assume they have solved the puzzle when a patient reacts to an allergen on patch testing, Adler cautioned. Two further steps matter:

• Confirm actual exposure to the allergen, "which is often a challenge"
• Show "sustained improvement following consistent avoidance of the allergen" to "really seal the deal"

The gold data illustrate the gap between a positive result and clinical relevance. Thimerosal reactions follow the same pattern: patients may test positive to the preservative, but those reactions are rarely meaningful. "It's not in any cosmetics at this point in time," Adler said, and "a positive reaction does not mean that the patient has any contraindication to any future vaccines."

Why aren't ingredient labels enough?

Some patients never read labels. Those who do can be misled or confused, Adler said. Consider three traps he highlighted:

• "Unscented" products may still contain fragrance — a common allergen — added to neutralize odor
• Fragrance itself may be described by hundreds of different ingredient names
• Preservatives that release formaldehyde do not explicitly say so on the label

Adler said he sometimes contacts manufacturers himself to confirm what a product actually contains.

What resources should dermatologists hand patients?

Rather than telling patients to avoid ingredients, Adler directs them to databases that flag specific products. His primary recommendation is the Contact Allergen Management Program (CAMP) from the American Contact Dermatitis Society — a regularly updated database of more than 100,000 products that designates items as "safe" or "not safe" based on a user's specific allergens.

"It's got a great phone app, a barcode scanner, and allergy handouts made by contact dermatitis experts," Adler said. One access caveat: patients can only use CAMP if their healthcare provider is an active society member who supplies allergen search codes.

SkinSAFE is another useful option, he said. The service, which offers free and premium tiers, says it ranks products "based on how free they are from the topmost common allergy-causing ingredients identified by Mayo Clinic."

Adler disclosed relationships with AbbVie, Dermavant Sciences, Castle, and UpToDate. For dermatologists running patch-testing clinics, his framework points toward a broader counseling role — pairing confirmed relevance and sustained avoidance with digital tools that keep patients on track between visits.